These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1643695

  • 21. Interactions of radiation and cancer chemotherapeutic drugs in a C3H mouse mammary carcinoma.
    von der Maase H, Overgaard J.
    Acta Radiol Oncol; 1985; 24(2):181-7. PubMed ID: 2988283
    [Abstract] [Full Text] [Related]

  • 22. Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences.
    Wang S, An R, Han X, Zhu K, Xue Y.
    Gynecol Oncol; 2006 Dec; 103(3):1105-8. PubMed ID: 16870237
    [Abstract] [Full Text] [Related]

  • 23. Effect of methylprednisolone on cell proliferation in C3H/HeJ spontaneous mammary tumors.
    Braunschweiger PG, Stragand JJ, Schiffer LM.
    Cancer Res; 1978 Dec; 38(12):4510-4. PubMed ID: 719635
    [No Abstract] [Full Text] [Related]

  • 24. Schedule-dependent potentiation of chemotherapeutic drugs by the bioreductive compounds NLCQ-1 and tirapazamine against EMT6 tumors in mice.
    Papadopoulou MV, Ji M, Bloomer WD.
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):160-8. PubMed ID: 11561782
    [Abstract] [Full Text] [Related]

  • 25. Local delivery of chemotherapy prolongs survival in experimental brain metastases from breast carcinoma.
    Ewend MG, Sampath P, Williams JA, Tyler BM, Brem H.
    Neurosurgery; 1998 Nov; 43(5):1185-93. PubMed ID: 9802862
    [Abstract] [Full Text] [Related]

  • 26. Potentiation of etoposide and vincristine by two synthetic 1,4-dihydropyridine derivatives in multidrug-resistant and atypical multidrug-resistant human cancer cells.
    Watanabe Y, Takano H, Kiue A, Kohno K, Kuwano M.
    Anticancer Drug Des; 1991 Feb; 6(1):47-57. PubMed ID: 2015041
    [Abstract] [Full Text] [Related]

  • 27. The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors. VI. BCNU.
    Lelieveld P, Twentyman PR, Kallman RF, Brown JM.
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1549-52. PubMed ID: 536261
    [No Abstract] [Full Text] [Related]

  • 28. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
    Yamauchi T, Hida S, Ooishi K, Okada K, Yoshida O.
    Hinyokika Kiyo; 1985 Jul; 31(7):1093-104. PubMed ID: 2414981
    [Abstract] [Full Text] [Related]

  • 29. CAI: effects on cytotoxic therapies in vitro and in vivo.
    Teicher BA, Holden SA, Chen YN, Ara G, Korbut TT, Northey D.
    Cancer Chemother Pharmacol; 1994 Jul; 34(6):515-21. PubMed ID: 7923563
    [Abstract] [Full Text] [Related]

  • 30. [Experimental study of CF chemotherapy, combined with another one chemotherapeutic drug against head and neck cancer cell lines].
    Tsukuda M, Mochimatsu I, Kokatsu T, Ito K, Furukawa S, Inoue T, Watanabe S, Sawaki S.
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):553-6. PubMed ID: 1373052
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.
    Martelli M, Vignetti M, Zinzani PL, Gherlinzoni F, Meloni G, Fiacchini M, De Sanctis V, Papa G, Martelli MF, Calabresi F, Tura S, Mandelli F.
    J Clin Oncol; 1996 Feb; 14(2):534-42. PubMed ID: 8636768
    [Abstract] [Full Text] [Related]

  • 37. Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.
    Rigacci L, Carrai V, Nassi L, Alterini R, Longo G, Bernardi F, Bosi A.
    Cancer; 2005 Mar 01; 103(5):970-7. PubMed ID: 15666323
    [Abstract] [Full Text] [Related]

  • 38. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA, Sirotnak FM, Otter GM, DeGraw JI.
    Cancer Treat Rep; 1987 Mar 01; 71(7-8):727-32. PubMed ID: 3607784
    [Abstract] [Full Text] [Related]

  • 39. Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells.
    Bowen D, Southerland WM, Johnson DH, Hawkins M, Hughes DE.
    Cancer Detect Prev; 2000 Mar 01; 24(5):452-8. PubMed ID: 11129987
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.